Abstract:C-X-C chemokine receptor type 4 (CXCR4), also known as fusin or CD184, is a 7-transmembrane helix G-protein-coupled receptor that is encoded by the CXCR4 gene. Involved in various physiological processes, CXCR4 could form an interaction with its endogenous partner, chemokine ligand 12 (CXCL12), which is also named SDF-1. In the past several decades, the CXCR4/CXCL12 couple has attracted a large amount of research interest due to its critical functions in the occurrence and development of refractory diseases, such as HIV infection, inflammatory diseases, and metastatic cancer, including breast cancer, gastric cancer, and non-small cell lung cancer. Furthermore, overexpression of CXCR4 in tumor tissues was shown to have a high correlation with tumor aggressiveness and elevated risks of metastasis and recurrence. The pivotal roles of CXCR4 have encouraged an effort around the world to investigate CXCR4-targeted imaging and therapeutics. In this review, we would like to summarize the implementation of CXCR4-targeted radiopharmaceuticals in the field of various kinds of carcinomas. The nomenclature, structure, properties, and functions of chemokines and chemokine receptors are briefly introduced. Radiopharmaceuticals that could target CXCR4 will be described in detail according to their structure, such as pentapeptide-based structures, heptapeptide-based structures, nonapeptide-based structures, etc. To make this review a comprehensive and informative article, we would also like to provide the predictive prospects for the CXCR4-targeted species in future clinical development.

Research progress about CXCR4 and tumor

Research Progress of CXCR4-Targeting Radioligands for Oncologic Imaging

Expression and Clinical Significance of the CXC Chemokine Receptor-4 (CXCR4) in Breast Cancer

CXCR4-Targeted Radiopharmaceuticals for the Imaging and Therapy of Malignant Tumors

The Advances in Chemokine Receptors CXCR1/2 and Cancer

Research progress of SDF-1/CXCR4 and biological behaviors of tumor

The chemokine receptors CXCR4 and CXCR7 in cancer

Research progress on SDF-1/CXCR4 axis in tumor

The molecular mechanism of CXCR4/SDF-1 in tumor signal transduction

The Role of CXCR3 and Its Ligands in Cancer

CXCL12 / CXCR4 / CXCR7 chemokine axis and cancer progression

CXCL12/CXCR4 and breast cancer

CXC chemokine receptor 4 (CXCR4) blockade in cancer treatment

The CXCL12 (SDF-1)/CXCR4 Chemokine Axis: Oncogenic Properties, Molecular Targeting, and Synthetic and Natural Product CXCR4 Inhibitors for Cancer Therapy.

The expression of chemokine receptor CXCR4 in colorectal cancer and its clinical significance

Roles of CXCL12/CXCR4 axis in tumor growth and metastasis and related mechanisms

Research Progress about CXCL12/CXCR4 in Renal Carcinoma

CXCL4 and Its Receptor in Colorectal Cancer

CXCL12/CXCR4: a symbiotic bridge linking cancer cells and their stromal neighbors in oncogenic communication networks

CXC Chemokine Receptors in the Tumor Microenvironment and an Update of Antagonist Development

Effect of CXCR7 on Tumor Development,Angiogenesis and Immune Reaction